Literature DB >> 33576710

Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France.

Florence Esselin1, Elisa De La Cruz1, Nicolas Pageot1, Raul Juntas-Moralès2, Sébastien Alphandéry1, William Camu1.   

Abstract

Covid-19-related lockdown (LD) in France precluded in-person follow-up in referral ALS centers. ALS patients' evolution and worsening before and during LD were studied to analyze its impact. A total of 84 patients were identified. The monthly rate of ALSFRS-R decline during LD was 1.06 ± 1.42 and was significantly increased compared to the pre-LD period, 0.58 ± 0.73, corresponding to an 83% increase (p = 0.007). Weight loss was unchanged between pre-LD and LD, gender and site of onset did not influence the rates of change of ALSFRS-R score. Several factors may be implicated in this increased severity of ALS during LD, such as psychological consequences of LD, interruptions of physiotherapy and speech therapy, or in-patient visits both to the tertiary center and the GP. Physicians and health authorities should be aware of that, in order to prevent the consequences of future sanitary restrictions.

Entities:  

Keywords:  ALSFRS-R; Amyotrophic lateral sclerosis; Covid-19; lockdown; worsening

Year:  2021        PMID: 33576710     DOI: 10.1080/21678421.2021.1883669

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  2 in total

1.  Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis.

Authors:  Shelagh K Genuis; Westerly Luth; Tania Bubela; Wendy S Johnston
Journal:  BMC Neurol       Date:  2022-04-12       Impact factor: 2.474

2.  Infection rate, mortality and characteristics of veterans with amyotrophic lateral sclerosis with COVID-19.

Authors:  Marinella D Galea; Vincent P Galea; Adam C Eberhart; Huned S Patwa; Ileana Howard; Christina N Fournier; Richard S Bedlack
Journal:  Muscle Nerve       Date:  2021-07-30       Impact factor: 3.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.